Generic vs brand name

Generic drugs are FDA-approved medications with the same active ingredients as brand-name drugs, but sold under chemical names rather than brand names. Insurers like Aetna and UnitedHealthcare usually cover generics at lower copays than brands, typically saving members 80–85% compared to brand prices, as stated by YourInsuranceInfo.

Generics meet the same strict FDA quality, safety, and efficacy standards as brands like Lipitor or Nexium. Most Medicare Part D plans group generics in tier 1 formularies, while brands like Crestor often fall in higher tiers with higher cost-sharing.

The FDA requires generic versions of drugs such as Metformin or Simvastatin to deliver equivalent therapeutic effects as their brand counterparts Glucophage or Zocor. In 2022, over 90% of prescriptions filled in the US were for generics (IQVIA Institute).

Pharmacy Benefit Managers (PBMs) incentivize pharmacies to dispense generics over brands due to significantly lower acquisition costs. Patients prescribed a brand drug like Advair Diskus can request a generic equivalent (such as Wixela Inhub), pending prescriber approval.

State laws in California, Texas, and New York mandate pharmacists substitute generics unless “dispense as written” is specified by the provider. Insurance formularies may require prior authorization for certain brands while automatically covering generics like Sertraline instead of Zoloft.

High-deductible health plans often pass full brand costs onto consumers until deductibles are met, making generics financially preferable whenever available.